2018

Avenell, A, Robertson, C, Skea, Z, Jacobsen, E, Boyers, D, Cooper, C, Aceves-Martins, M, Retat, L, Fraser, C, Aveyard, P, Stewart, F, MacLennan, G, Webber, L, Corbould, E, Xu, B, Jaccard, A, Boyle, B, Duncan, E, Shimonovich, M,de Bruin, M. Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation. Health Technology Assessment (Winchester, England) 2018;22(68).

Brazzelli, M, Hernandez, R, Sharma, P, Robertson, C, Shimonovich, M, MacLennan, G, Fraser, C, Jamieson, R,Vallabhaneni, SR. Contrast-enhanced ultrasound and/or colour duplex ultrasound for surveillance after endovascular abdominal aortic aneurysm repair: a systematic review and economic evaluation. Health Technology Assessment (Winchester, England) 2018;22(72):1-220.

Brazzelli M, Javanbakht M, Imamura M, Hudson J, Moloney E, Becker F, Wallace S, Omar MI, Shimonovich M, Maclennan G, Ternent L, Vale L, Montgomery I, Mackie P, Saraswat L, Monga A,  Craig D. The Effectiveness and cost-effectiveness of Surgical Treatments for womEn with stRess urinary incontinence (ESTER): An evidence synthesis, economic evaluation and discrete choice experiment. Technology Assessment Report submitted to the NIHR HTA Programme. University of Aberdeen: Health Services Research Unit; 2018

Cummins E, Aucott L, Robertson C, Fraser C, Johnston R, Lam T,  Brazzelli M. Abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2018

 

Hernandez R, Cruickshank AM, Dimitrova M, Cooper D, Aucott L, Fraser C, Shimonovich M, Ormerod A, Scotland G,  Brazzelli M. Dupilumab for treating adults with moderate to severe atopic dermatitis. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2018

 

2017

Boyers, D, Cruickshank, M, Jacobsen, E, Cooper, D, Fraser, C, Culligan, D,Scotland, G. Brentuximab vedotin for relapsed or refractory systemic anaplastic large cell lymphoma. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2017

 

Brazzelli, M, Hernandez, R, Sharma, P, Robertson, C, Shimonovich, M, MacLennan, G, Fraser, C, Jamieson, R,Vallabhaneni, S. The clinical and cost-effectiveness of protocols using contrast-enhanced ultrasound and/or colour duplex ultrasound in the long-term surveillance of endovascular abdominal aortic aneurysm repair: an evidence synthesis and economic evaluation. Technology Assessment Report submitted to the NIHR HTA Programme. University of Aberdeen: Health Services Research Unit; 2017

 

Brazzelli, M, Cummins, E, Fielding, S, Cruickshank, M, Fraser, C, Azuara-Blanco, A. Aflibercept for treating myopic choroidal neovascularisation. Fast track appraisal: cost comparison case. Evidence Review Group Report in support of NICE Fast Track Appraisal Programme. London: National Institute for Health and Care Excellence; 2017

 

Independent Review Group on Transvaginal Mesh Implants, Glazener, C. The Scottish Independent Review of the use, safety and efficacy of transvaginal mesh implants in the treatment of stress urinary incontinence and pelvic organ prolapse in women. . Final Report. Edinburgh: The Scottish Government; 2017

 

Scotland, G, Cruickshank, M, Jacobsen, E, Cooper, D, Fraser, C, Shimonovich, M, Marks, A,Brazzelli, M. Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis. Diagnostic assessment report in support of the NICE Diagnostic Assessment Programme. University of Aberdeen: Health Services Research Unit; 2017

 

Scotland, G, Kopasker, D, Scott, N, Cruickshank, M, Hernandez, R, Fraser, C, McLean, M, McKinlay, A,Brazzelli, M. Teduglutide for treating short bowel syndrome. Evidence Review Group report in support of NICE STA programme. London: National Institute for Health and Care Excellence; 2017

2016

Brazzelli, M, Hawkins, N, McKeekin, N, Goulao, B, Cooper, D, Sharma, P, Fraser, C, Nicolson, M,Wu, O. Pembrolizumab after platinum chemotherapy for treating advanced, recurrent, PD-L1 positive, non-small cell lung cancer. . Evidence Review Group report in support of the NICE STA University of Aberdeen: Health Services Research Unit; 2016

 

Cummins, E, Culligan, D, Cooper, D, Fraser, C, Robertson, C,Ramsay, C, R. Ibrutinib for treating relapsed or refractory chronic lymphocytic leukaemia Evidence Review Group report in support of the NICE STA Programme. University of Aberdeen: Health Services Research Unit; 2016

 

Cummins, E, Ayansina, D, Sharma, P, Fraser, C, Shimonovich, M, McLean, M,Brazzelli, M. Eluxadoline for treating irritable bowel syndrome with diarrhoea. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2016

 

Scotland, G, Hernandez, R, Robertson, C, Scott, N,Fraser, C. Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases (men who have not received docetaxel and for whom docetaxel is contraindicated or not suitable).

ERG critique of the company submission for re-consideration of current CDF technologies under the new proposed CDF criteria. University of Aberdeen: Health Services Research Unit; 2016

 

Scott, N, Cummins, E, Cruickshank, M, Fraser, C, Lois, N,Brazzelli, M. Aflibercept for treating visual impairment due to macular oedema secondary to branch vein occlusion: a single technology appraisal. . Evidence Review Group report in support of the NICE STA Programme. . University of Aberdeen: Health Services Research Unit; 2016

2015

Cruickshank, M, Henderson, L, MacLennan, G, Fraser, C, Campbell, M, Blackwood, B, Gordon, A,Brazzelli, M. Alpha2-agonists for sedation of mechanically-ventilated adults in intensive care units: a systematic review. Technology Assessment Report submitted to the NIHR HTA Programme. University of Aberdeen: Health Services Research Unit; 2015

 

Cummins E, Scott N, Cruickshank M, Fraser C, Ormerod A, Brazzelli M.  Secukinumab for treating moderate to severe plaque psoriasis. Evidence Review Group report in support of the NICE STA Programme.  University of Aberdeen: Health Services Research Unit; 2015.

 

Glazener, C, Breeman, S, Elders, A, Hemming, C, Cooper, K, Freeman, RF, Smith, A, Hagen, S, Montgomery, I, Kilonzo, M, Boyers, D, Maclennan, G, McDonald, A, McPherson, G,Norrie , J. Clinical and cost-effectiveness of surgical options for the management of anterior and/or posterior vaginal wall prolapse: two randomised controlled trials within a comprehensive cohort study: results from the PROSPECT Study Final grant report submitted to the NIHR HTA programme. University of Aberdeen: Health Services Research Unit; 2015

 

Independent Review Group on Transvaginal Mesh Implants [Glazener, C]. The Scottish Independent Review of the Use, Safety and Efficacy of Transvaginal Mesh Implants in the Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse in Women. Interim Report. Edinburgh: The Scottish Government; 2015

 

Robertson C, Lam T, Fielding S, Cummins E, Fraser C, Scotland G et al.  Enzalutamide for treating metastatic hormone-relapsed prostate cancer not previously treated with chemotherapy. Evidence Review Group report in support of the NICE STA Programme.  University of Aberdeen; Health Services Research Unit: 2015.

 

Scotland, G, Javanbakht, M, Scott, N, Cruickshank, M, Sharma, P, Fraser, C, Simpson, W,Brazzelli, M. Ezetimibe for treating primary (heterozygous-familial and non-familial) hypercholesterolaemia. . Evidence Review Group report in support of the NICE STA Programme. University pf Aberdeen: Health Services Research Unit; 2015

 

Scotland, G, Neilson, A, Javanbakht, M, Fielding, S, Cruickshank, M, Sharma, P, Fraser, C, Simpson, W,Brazzelli, M. Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia. Evidence Review Group report in support of the NICE STA Programme. University of Aberdeen: Health Services Research Unit; 2015

 

Sharma P, Boyers D, Scott N, Hernandez R, Fraser C, Cruickshank M et al.  The clinical and cost-effectiveness of open mesh repairs in adults presenting with a clinically diagnosed unilateral, primary inguinal hernia who are operated in an elective setting: systematic review and economic evaluation. Technology Assessment Report submitted to the NIHR HTA Programme.  University of Aberdeen: Health Services Research Unit; 2015.

2014

Aucott L, Philip S, Avenell A, Sattar N, Wild S.  Patterns Of Weight Changes After Diagnosis In Patients With Type 2 Diabetes And Their Relationship With Metabolic and Cardiovascular Outcomes. Final grant report submitted to the Chief Scientist Office.  University of Aberdeen: 2014.

 

Adam E, McKee L.  Unscheduled Care and Support for Decision-Making: Consultancy Report. University of Aberdeen: Health Services Research Unit; 2014.

 

Azuara-Blanco A, Banister K, Boachie C, McMeekin P, Gray J, Burr J et al.  Comparative study of automated imaging technologies for the diagnosis of glaucoma (GATE study). Diagnostic accuracy, performance as triage tests, and cost-effectiveness. Final grant reported submitted to the NIHR HTA Programme.  University of Aberdeen: Health Services Research Unit; 2014.

 

Brazzelli M, Cruickshank M, Tassie E, Robertson C, McNamee P, Hernandez R et al.  Collagenase clostridium histolyticum for the treatment  of Dupuytren's contracture. Technology Assessment Report submitted to the National Institute for Health & Care Excellence.  University of Aberdeen: Health Services Research Unit; 2014.

 

Fielding S, Cummins E, Cruickshank M, Fraser C, Lois N, Brazzelli M.  Aflibercept for treating diabetic macular oedema. Evidnce Review Group Report in support of the NICE STA Programme.  University of Aberdeen: Health Services Research Unit; 2014.

 

Robertson C, Archibald D, Avenell A, Douglas F, Hoddinott P, van Teijlingen E et al.  Systematic reviews and integrated report on the quantitative, qualitative and economic evidence base for the management of obesity in men. Final grant report submitted to the NIHR HTA Programme.  University of Aberdeen: Health Services Research Unit; 2014.

2013

Cummins E, Fielding S, Johnston R, Rothnie K, Stewart F, Lois N et al.  Aflibercept solution for injection for the treatment of wet age-related macular degeneration. Evidence Review Group report in support of NICE STA Programme.  University of Aberdeen: Health Services Research Unit; 2013.

 

Cummins E, Fielding S, Cruickshank M, Fraser C, Lois N, Brazzelli M.  Ranibizumab for the treatment of choroidal neovascularisation associated with pathological myopia. A Single Technology Appraisal. Evidence Review Group report in support of NICE STA programme.  University of Aberdeen: Health Services Research Unit; 2013.

 

Cummins E, Scott N, Rothnie K, Waugh N, Fraser C, Philip S et al.  Dapagliflozin for the treatment of type 2 diabetes: A Single Technology Appraisal. Evidence Review Group report in support of NICE STA programme.  University of Aberdeen: Health Services Research Unit; 2013.

 

The SCARLESS Study Group, [Ahmed A], [Krukowski Z], [McCormack K], [Cook JA], [McDonald A] et al.  Single port/incision laparoscopic surgery compared with standard 3 port laparoscopic surgery for appendicectomy - a randomised controlled trial. Final grant report submitted to the Chief Scientist Office.  University of Aberdeen: Health Services Research Unit; 2013.

 

West M, Baker R, Dawson J, Dixon-Woods M, Lilford R, Martin G et al.  Quality and safety in the NHS: evaluating progress, problems and promise. Final grant report submitted to the Department of Health.  Lancaster University; 2013.

2012

Burr JM, Botello AP, Takwongi Y, Hernandez R, Vazquez-Montes M, Elders A et al.  Surveillance for ocular hypertension: evidence synthesis and economic evaluation. Final grant report submitted to NIHR HTA programme.  University of Aberdeen: Health Services Research Unit; 2012.

 

Cummins E, Fielding S, Cruickshank M, Fraser C, Lois N, Brazzelli M.  Ranibizumab for the treatment of choroidal neovascularisation associated with pathological myopia. A Single Technology Appraisal. Evidence Review Group report in support of NICE STA programme.  University of Aberdeen: Health Services Research Unit; 2013.

 

Cummins E, Fielding S, Scott N, Rothnie K, Crowther M, Fraser C et al.  Eltrombopag for the treatment of chronic immune thrombocytopenic purpura: A Single Technology Appraisal. Evidence Review Group report in support of NICE STA programme.  University of Aberdeen: Health Services Research Unit; 2012.

 

Hoddinott P, Britten J, McInnes R, Craig L, Darwent K.  Significant others, situations and their influence on infant feeding. Final grant report submitted to NHS Scotland.  University of Aberdeen: Health Services Research Unit; 2012.